Partners & Investors

Home Partners & Investors

Coming Soon

OROX BioSciences harnesses the beneficial effects of inhibiting sEH selectively or in concert with secondary targets to gain efficacy and bring about resolution to disease states such as fibrosis.

QUICK LINKS

Our Company
Our Science
Therapeutic Programs
Project Status
Partners & Investors
Academic Collaborations
Careers

News and Publications

A Proposed ADME Optimization Workflow for Covalent Inhibitors.

Drug Discovery Chemistry Symposium (San Diego, CA) April-6-2018

Designed & Developed by Perfecent